TY  - GEN
AU  - Peter,B
AU  - Bibi,S
AU  - Eisenwort,G
AU  - Wingelhofer,B
AU  - Berger,D
AU  - Stefanzl,G
AU  - Blatt,K
AU  - Herrmann,H
AU  - Hadzijusufovic,E
AU  - Hoermann,G
AU  - Hoffmann,T
AU  - Schwaab,J
AU  - Jawhar,M
AU  - Willmann,M
AU  - Sperr,W R
AU  - Zuber,J
AU  - Sotlar,K
AU  - Horny,H-P
AU  - Moriggl,R
AU  - Reiter,A
AU  - Arock,M
AU  - Valent,P
TI  - Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
SN  - 1476-5551
PY  - 2019///0219
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Animals
KW  - Apoptosis
KW  - drug effects
KW  - Cell Cycle Checkpoints
KW  - Cell Line, Tumor
KW  - Dasatinib
KW  - pharmacology
KW  - Dogs
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - Female
KW  - G2 Phase Cell Cycle Checkpoints
KW  - Humans
KW  - Leukemia, Mast-Cell
KW  - drug therapy
KW  - Male
KW  - Mast Cells
KW  - Mastocytosis, Systemic
KW  - Middle Aged
KW  - Norbornanes
KW  - Phosphorylation
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins c-kit
KW  - metabolism
KW  - Pyrimidines
KW  - STAT5 Transcription Factor
KW  - Staurosporine
KW  - analogs & derivatives
KW  - Tumor Suppressor Proteins
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2017.338
ER  -